ELONOX HP DIN 02532328
Health Canada record
| Active ingredient(s) | ENOXAPARIN SODIUM 150 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B01AB05 ENOXAPARIN |
| Original market date | 17-Mar-2023 |
| Current status date | 17-Mar-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Fresenius Kabi Canada Ltd. — licence 102232, currently licensed, last inspection rating C (2025-10-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ENOXAPARIN SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02540002 | AXBERI | BAXTER CORPORATION | Solution | ENOXAPARIN SODIUM 60 MG | Marketed |
| 02539985 | AXBERI | BAXTER CORPORATION | Solution | ENOXAPARIN SODIUM 40 MG | Marketed |
| 02540045 | AXBERI | BAXTER CORPORATION | Solution | ENOXAPARIN SODIUM 100 MG | Marketed |
| 02539977 | AXBERI | BAXTER CORPORATION | Solution | ENOXAPARIN SODIUM 30 MG | Marketed |
| 02540010 | AXBERI | BAXTER CORPORATION | Solution | ENOXAPARIN SODIUM 80 MG | Marketed |
| 02540029 | AXBERI HP | BAXTER CORPORATION | Solution | ENOXAPARIN SODIUM 120 MG | Marketed |
| 02540037 | AXBERI HP | BAXTER CORPORATION | Solution | ENOXAPARIN SODIUM 150 MG | Marketed |
| 02532255 | ELONOX | FRESENIUS KABI CANADA LTD | Solution | ENOXAPARIN SODIUM 40 MG | Marketed |
| 02532247 | ELONOX | FRESENIUS KABI CANADA LTD | Solution | ENOXAPARIN SODIUM 30 MG | Marketed |
| 02532298 | ELONOX | FRESENIUS KABI CANADA LTD | Solution | ENOXAPARIN SODIUM 100 MG | Marketed |
| 02532271 | ELONOX | FRESENIUS KABI CANADA LTD | Solution | ENOXAPARIN SODIUM 80 MG | Marketed |
| 02532263 | ELONOX | FRESENIUS KABI CANADA LTD | Solution | ENOXAPARIN SODIUM 60 MG | Marketed |
| 02532301 | ELONOX HP | FRESENIUS KABI CANADA LTD | Solution | ENOXAPARIN SODIUM 120 MG | Marketed |
| 02507501 | INCLUNOX | SANDOZ CANADA INCORPORATED | Solution | ENOXAPARIN SODIUM 30 MG | Marketed |
| 02507552 | INCLUNOX | SANDOZ CANADA INCORPORATED | Solution | ENOXAPARIN SODIUM 100 MG | Marketed |
| 02507544 | INCLUNOX | SANDOZ CANADA INCORPORATED | Solution | ENOXAPARIN SODIUM 80 MG | Marketed |
| 02507536 | INCLUNOX | SANDOZ CANADA INCORPORATED | Solution | ENOXAPARIN SODIUM 60 MG | Marketed |
| 02507528 | INCLUNOX | SANDOZ CANADA INCORPORATED | Solution | ENOXAPARIN SODIUM 40 MG | Marketed |
| 02507560 | INCLUNOX HP | SANDOZ CANADA INCORPORATED | Solution | ENOXAPARIN SODIUM 120 MG | Marketed |
| 02507579 | INCLUNOX HP | SANDOZ CANADA INCORPORATED | Solution | ENOXAPARIN SODIUM 150 MG | Marketed |
| 02378434 | LOVENOX | SANOFI-AVENTIS CANADA INC | Solution | ENOXAPARIN SODIUM 80 MG | Marketed |
| 02236883 | LOVENOX | SANOFI-AVENTIS CANADA INC | Solution | ENOXAPARIN SODIUM 40 MG | Marketed |
| 02378426 | LOVENOX | SANOFI-AVENTIS CANADA INC | Solution | ENOXAPARIN SODIUM 60 MG | Marketed |
| 02378442 | LOVENOX | SANOFI-AVENTIS CANADA INC | Solution | ENOXAPARIN SODIUM 100 MG | Marketed |
| 02012472 | LOVENOX | SANOFI-AVENTIS CANADA INC | Solution | ENOXAPARIN SODIUM 30 MG | Marketed |
| 02378469 | LOVENOX HP | SANOFI-AVENTIS CANADA INC | Solution | ENOXAPARIN SODIUM 150 MG | Marketed |
| 02242692 | LOVENOX HP | SANOFI-AVENTIS CANADA INC | Solution | ENOXAPARIN SODIUM 120 MG | Marketed |
| 02236564 | LOVENOX WITH PRESERVATIVE 300MG/3ML | SANOFI-AVENTIS CANADA INC | Solution | ENOXAPARIN SODIUM 100 MG | Marketed |
| 02506475 | NOROMBY | JUNO PHARMA CANADA INC. | Solution | ENOXAPARIN SODIUM 60 MG | Marketed |
| 02506491 | NOROMBY | JUNO PHARMA CANADA INC. | Solution | ENOXAPARIN SODIUM 100 MG | Marketed |
| 02506440 | NOROMBY | JUNO PHARMA CANADA INC. | Solution | ENOXAPARIN SODIUM 20 MG | Approved |
| 02506459 | NOROMBY | JUNO PHARMA CANADA INC. | Solution | ENOXAPARIN SODIUM 30 MG | Marketed |
| 02506483 | NOROMBY | JUNO PHARMA CANADA INC. | Solution | ENOXAPARIN SODIUM 80 MG | Marketed |
| 02506467 | NOROMBY | JUNO PHARMA CANADA INC. | Solution | ENOXAPARIN SODIUM 40 MG | Marketed |
| 02506513 | NOROMBY HP | JUNO PHARMA CANADA INC. | Solution | ENOXAPARIN SODIUM 150 MG | Marketed |
| 02506505 | NOROMBY HP | JUNO PHARMA CANADA INC. | Solution | ENOXAPARIN SODIUM 120 MG | Marketed |
| 02509083 | REDESCA | SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD. | Solution | ENOXAPARIN SODIUM 40 MG | Marketed |
| 02509121 | REDESCA | SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD. | Solution | ENOXAPARIN SODIUM 300 MG | Marketed |
| 02509075 | REDESCA | SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD. | Solution | ENOXAPARIN SODIUM 30 MG | Marketed |
| 02509113 | REDESCA | SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD. | Solution | ENOXAPARIN SODIUM 100 MG | Marketed |
| 02509105 | REDESCA | SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD. | Solution | ENOXAPARIN SODIUM 80 MG | Marketed |
| 02509091 | REDESCA | SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD. | Solution | ENOXAPARIN SODIUM 60 MG | Marketed |
| 02509156 | REDESCA HP | SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD. | Solution | ENOXAPARIN SODIUM 150 MG | Marketed |
| 02509148 | REDESCA HP | SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD. | Solution | ENOXAPARIN SODIUM 120 MG | Marketed |
| 02378450 | LOVENOX HP | SANOFI-AVENTIS CANADA INC | Solution | ENOXAPARIN SODIUM 90 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 29299 | 2022-10-26 | New Drug Submission (NDS) |
International API supply for ENOXAPARIN SODIUM
2 valid EDQM Certificates of Suitability from 2 holders. 14 active FDA Drug Master Files.
Request a quote for ELONOX HP